Publications of Lars Pelz
All genres
Journal Article (6)
2024
Journal Article
Göbel, S., Pelz, L., , , , , , Reichl, U., & Genzel, Y. (2024)Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtrationApplied Microbiology and Biotechnology, 108 (1), 240doi: 10.1007/s00253-024-13078-6.
Journal Article
Pelz, L., Dogra, T., Marichal-Gallardo, P., , Hemissi, G., Kupke, S. Y., Genzel, Y., & Reichl, U. (2024)Production of antiviral “OP7 chimera” defective interfering particles free of infectious virusApplied Microbiology and Biotechnology, 108, 97doi: 10.1007/s00253-023-12959-6.
2023
Journal Article
Dogra, T., Pelz, L., , Küchler, J., , Marichal-Gallardo, P., , , , Benndorf, D., Genzel, Y., , Kupke, S. Y., & Reichl, U. (2023)Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in miceScientific Reports, 13, 20936doi: 10.1038/s41598-023-47547-1.
Journal Article
Pelz, L., Piagnani, E., Marsall, P., , , Marichal-Gallardo, P., Kupke, S. Y., & Reichl, U. (2023)Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In VitroViruses, 15 (9), 1872doi: 10.3390/v15091872.
2021
Journal Article
Pelz, L., Rüdiger, D., Dogra, T., , Genzel, Y., , Kupke, S. Y., & Reichl, U. (2021)Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapyJournal of Virology, 95 (24), e01174-21doi: 10.1128/JVI.01174-21.
Journal Article
Rüdiger, D., Pelz, L., , Kupke, S. Y., & Reichl, U. (2021)Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culturePLoS Computational Biology, 17, e1009357doi: 10.1371/journal.pcbi.1009357.
Book Chapter (2)
2023
Book Chapter
Göbel, S., Pelz, L., Reichl, U., & Genzel, Y. (2023)Upstream processing for viral vaccines - Process intensificationBioprocessing of Viral Vaccines137–174.
Book Chapter
Pelz, L., Göbel, S., , Reichl, U., & Genzel, Y. (2023)Upstream processing for viral vaccines – General aspectsBioprocessing of Viral Vaccines79–136.
Meeting Abstract (2)
2023
Meeting Abstract
Pelz, L., Dogra, T., Kupke, S. Y., & (2023)Characterization of the local innate immune response after mucosal application of IAV Defective Interfering ParticlesIn: European Journal of Immunology, P339doi: 10.1002/eji.202370300.
, , , 2022
Meeting Abstract
Göbel, S., Pelz, L., Behrendt, I., , , , , Genzel, Y., & Reichl, U. (2022)Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionIn: Proceedings Single-Use Technologies V: Building the Future, 40.
Talk (16)
2024
Talk
Pelz, L., Rüdiger, D., , , , , Marichal-Gallardo, P., , Genzel, Y., , Kupke, S. Y., & Reichl, U.Engineered defective interfering particles of influenza A virus for antiviral treatmentPresented at: 33rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.
Talk
Pelz, L., Rüdiger, D., , , , , Marichal-Gallardo, P., , Genzel, Y., , Kupke, S. Y., & Reichl, U.Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.
2023
Talk
Dogra, T., Pelz, L., , , , Marichal-Gallardo, P., , Genzel, Y., , Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 17th Vaccine CongressGlasgow (Scotland), September 24, 2023.
Talk
Dogra, T., Pelz, L., Rüdiger, D., Kupke, S. Y., & Reichl, U.Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: Vir-AI-DIP Workshop Hamburg (Germany), July 18, 2023.
Talk
Göbel, S., Jaén, K. E., Pelz, L., , , Reichl, U., & Genzel, Y.Intensifiying OSB processes for high titer virus productionPresented at: 5th large scale meeting: Orbital shaken bioreactorsGirona (Spain), June 5, 2023.
Talk
Kupke, S. Y., Dogra, T., Pelz, L., , , , , , , , , , , & Reichl, U.Influenza A virus defective interfering particles as antiviral agentsPresented at: 32nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.
Talk
Pelz, L., Dogra, T., , , Marichal-Gallardo, P., Genzel, Y., , Kupke, S. Y., & Reichl, U.Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivoPresented at: Cell Culture Engineering (CCE) XVIII Cancun (Mexico), April 23, 2023.
Talk
Pelz, L., Genzel, Y., Kupke, S. Y., & Reichl, U.In-depth characterization and cell culture-based production of influenza A virus defective interfering particlesPresented at: ACTIP fellowship sessionDublin (Ireland), October 11, 2023.
Talk
Pelz, L., Rüdiger, D., Dogra, T., , Genzel, Y., , Kupke, S. Y., & Reichl, U.Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral TherapyPresented at: Vir-AI-DIP WorkshopHamburg (Germany), July 18, 2023.
Talk
Rüdiger, D., Pelz, L., , Kupke, S. Y., & Reichl, U.Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culturePresented at: Vir-AI-DIP WorkshopHamburg (Germany), July 18, 2023.